Last reviewed · How we verify
Induction of labor with PGE2 — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Induction of labor with PGE2 (Induction of labor with PGE2) — Guangzhou Women and Children's Medical Center.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Induction of labor with PGE2 TARGET | Induction of labor with PGE2 | Guangzhou Women and Children's Medical Center | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Induction of labor with PGE2 CI watch — RSS
- Induction of labor with PGE2 CI watch — Atom
- Induction of labor with PGE2 CI watch — JSON
- Induction of labor with PGE2 alone — RSS
Cite this brief
Drug Landscape (2026). Induction of labor with PGE2 — Competitive Intelligence Brief. https://druglandscape.com/ci/induction-of-labor-with-pge2. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab